Insider sale
RAPPORT THERAPEUTICS, INC.
$17.18M
426K shares
What this filing means
THIRD ROCK VENTURES V, L.P. plans to sell 426K shares of RAPPORT THERAPEUTICS, INC. valued at approximately $17.18M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/17/2026ACC: 0001974078-26-000144
10% Owner
Since Jun 2024
426K
Shares to sell
$17.18M
Approx. market value
2.80M
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Original Issuance
Cash
2/21/2023
2.80MTotal acquired2.80M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/21/2023 | Original Issuance Cash | 2.80M | — |
| Total | 2.80M | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
426K
Market value
$17.18M
4/17/2026
Total
Units
426K
Value
$17.18M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/17/2026 | 426K | $17.18M | Nasdaq | Planned |
| Total | 426K | $17.18M | ||